Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06986824 · ClinicalTrials.gov registry record · Phase 4
Perineal Massage Using A Pelvic Wand During Pregnancy
A Phase 4 study of Pregnancy Related and Pelvic Floor Disorders, sponsored by Beth Israel Deaconess Medical Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT06986824: Recruiting Phase 4 study of Pregnancy Related and Pelvic Floor Disorders, sponsored by Beth Israel Deaconess Medical Center.
NCT06986824 is a Phase 4 study of Pregnancy Related and Pelvic Floor Disorders that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 140 participants, below the 1,962-participant average among 99 other Pregnancy Related trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06986824, a Phase 4 study of Pregnancy Related and Pelvic Floor Disorders, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
There is limited research on the optimal strategy to reduce obstetric laceration, postpartum urinary retention, and postpartum pelvic pain. In systematic reviews, clinician-directed massage of the perineal muscles at the time of birth and patient directed massage of the perineal muscles in the third trimester to inconsistently reduce the incidence of severe obstetric laceration.1,2 However, there is significant heterogeneity of these studies is due in large part to the lack of a standardized protocols and unpredictability of clinician availability to perform perineal massage around the time of birth. The purpose of this study is to understand how perineal massage with a pelvic wand in late pregnancy and during labor influences one's sense of self-control over the labor process and birth experience.
Primary Outcome
A clinically significant difference is defined as a mean score difference of 10 points
Conditions Studied
Interventions
- DEVICE Pelvic wand
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2026-09-01 |
| Phase | Phase 4 |
What NCT06986824 shows while recruiting
NCT06986824 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 1,962-participant average among 99 other Pregnancy Related trials with a reported enrollment target (93% lower).
The record links to 4 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 1 intervention - of which Pelvic wand is the first listed.
NCT06986824 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06986824 about?
NCT06986824 is a clinical study titled "Perineal Massage Using A Pelvic Wand During Pregnancy". There is limited research on the optimal strategy to reduce obstetric laceration, postpartum urinary retention, and postpartum pelvic pain. In systematic reviews, clinician-directed massage of the perineal muscles at the time of birth and patient directed massage of the perineal muscles in the third...
What is the current status of trial NCT06986824?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 140 participants. The study started on 2025-10-01. Estimated completion is 2026-09-01.
What conditions does trial NCT06986824 study?
This clinical trial studies the following conditions: Pregnancy Related, Pelvic Floor Disorders, Patient Empowerment, Obstetric; Injury.
What interventions are being tested in trial NCT06986824?
The interventions under investigation include: Pelvic wand (DEVICE).
Who is sponsoring clinical trial NCT06986824?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06986824 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06986824's enrollment target sits among peer trials
140 51st of 99 higher than 48 of 99 other Pregnancy Related trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy Related trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Antenatal Support for Iron Deficiency Anemia
RECRUITING · Phase 4
-
Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease
RECRUITING · Phase 4
-
Low Dose Aspirin for Preterm Preeclampsia Preventionmg/day Dose in High-risk Patients
ACTIVE NOT RECRUITING · Phase 4
-
Effects of Pregnancy-associated Hormones on THC Metabolism in Women
ACTIVE NOT RECRUITING · Phase 4
-
Misoprostol Dosing in BMI Greater Than 30
COMPLETED · Phase 4
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI